These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 2933836)

  • 21. [Controlled blind study of the effectiveness of hemosorption in rheumatoid arthritis].
    Matveĭkov GP; Tsarev VP; Titov LP
    Revmatologiia (Mosk); 1989; (2):15-9. PubMed ID: 2678390
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Role of immune complexes in the pathogenesis of a variety of chronic dermatoses].
    Skripkin IuK; Korotkiĭ NG; Udzhukhu VIu
    Vestn Dermatol Venerol; 1982 Aug; (8):24-30. PubMed ID: 6216680
    [No Abstract]   [Full Text] [Related]  

  • 23. [Correlation between immunopathologic renal lesions and circulating immune complexes in generalized lupus erythematosus in children].
    Vázquez-Escobosa C; Gortazar-Hijar P; González-Mendoza A
    Bol Med Hosp Infant Mex; 1984 Jul; 41(7):363-8. PubMed ID: 6236832
    [No Abstract]   [Full Text] [Related]  

  • 24. Immune deposits in the skin of patients with rheumatoid arthritis.
    McGill PE; Brougham PA; Tulloch J
    J Rheumatol; 1984 Aug; 11(4):454-6. PubMed ID: 6384506
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Use of hemosorption in the treatment of immune-complex lesions of the liver].
    Chuchalin AG; Masuev KA; Shurkalin BK; Evseev NG
    Ter Arkh; 1983; 55(10):39-43. PubMed ID: 6228027
    [No Abstract]   [Full Text] [Related]  

  • 26. [Demonstration of antinuclear antibodies in the epidermis of patients with progressive systemic sclerosis, generalized lupus erythematosus and dermatomyositis].
    Lamas Robles C; Mejía Arreguín S; Orozco Medina JH; González Mendoza A
    Rev Invest Clin; 1984; 36(2):115-9. PubMed ID: 6385174
    [No Abstract]   [Full Text] [Related]  

  • 27. Placental abnormalities in systemic lupus erythematosus: in situ deposition of antinuclear antibodies.
    Guzman L; Avalos E; Ortiz R; Gurrola R; Lopez E; Herrera R
    J Rheumatol; 1987 Oct; 14(5):924-9. PubMed ID: 2963129
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The connective tissue diseases and the overall influence of gender.
    Lahita RG
    Int J Fertil Menopausal Stud; 1996; 41(2):156-65. PubMed ID: 8829695
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Complement fixing immune complexes containing antinuclear antibodies in patients with systemic lupus erythematosus.
    Budd JJ; Moore TL; Osborn TG
    J Rheumatol; 1988 Feb; 15(2):247-50. PubMed ID: 3258914
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Hemosorption combined with plasmapheresis in rheumatoid arthritis patients].
    Bazhenov AN
    Vrach Delo; 1990 Feb; (2):32-4. PubMed ID: 2339546
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of therapeutic plasmapheresis in the rheumatic diseases.
    Jones JV; Clough JD; Klinenberg JR; Davis P
    J Lab Clin Med; 1981 May; 97(5):589-98. PubMed ID: 6452484
    [No Abstract]   [Full Text] [Related]  

  • 32. The immunofluorescent "band" test for lupus erythematosus. 3. Employing clinically normal skin.
    Burnham TK; Fine G
    Arch Dermatol; 1971 Jan; 103(1):24-32. PubMed ID: 4099590
    [No Abstract]   [Full Text] [Related]  

  • 33. Autoimmunity and immune complex disease after neonatal induction of transplantation tolerance in mice.
    Goldman M; Feng HM; Engers H; Hochman A; Louis J; Lambert PH
    J Immunol; 1983 Jul; 131(1):251-8. PubMed ID: 6223073
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Experience in using hemosorption in treating patients with rheumatoid arthritis].
    Kriklivets LS; Ginzburg SM; Mal'tsev VI; Medvedev AV; Didyk VS; Kriklivets IuI
    Vrach Delo; 1990 Nov; (11):50-1. PubMed ID: 2098983
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Circulating immune complexes (CIC) in connective tissue diseases (CTD).
    Schrieber L; Maini RN
    Neth J Med; 1984; 27(9):327-39. PubMed ID: 6239983
    [No Abstract]   [Full Text] [Related]  

  • 36. [Immunopathologic mechanism in some ocular diseases].
    Rogoz S; Avramescu C; Siloşi I; Drackoulogona O; Badea P; State A
    Oftalmologia; 2002; 54(3):51-5. PubMed ID: 12723199
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Lung involvement in immune complex diseases and 1st clinical use of hemosorption].
    Chuchalin AG; Masuev KA; Shurkalin BK; Evseev NG; Struchkov PV
    Ter Arkh; 1981; 53(11):15-8. PubMed ID: 6461936
    [No Abstract]   [Full Text] [Related]  

  • 38. Pathogenesis of connective tissue disease.
    Holborow EJ
    Trans Ophthalmol Soc U K (1962); 1974 Sep; 94(3):712-20. PubMed ID: 4282889
    [No Abstract]   [Full Text] [Related]  

  • 39. [Study of the immunocorrecting effect of hemosorption with plasmapheresis in neurodermatitis].
    Glukhen'kaia AB
    Vestn Dermatol Venerol; 1984 Aug; (8):6-8. PubMed ID: 6237515
    [No Abstract]   [Full Text] [Related]  

  • 40. [Immunoregulatory subpopulations of T-lymphocytes of systemic lupus erythematosus patients before and after hemosorption].
    Lysenko GI; Gandzha IM; Mel'nikov OF; Sambur MB
    Vrach Delo; 1987 Feb; (2):94-8. PubMed ID: 2883772
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.